This company listing is no longer active
Spectral MD Holdings Crecimiento futuro
Future controles de criterios 2/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Spectral MD Holdings.
Información clave
n/a
Tasa de crecimiento de los beneficios
n/a
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Medical Equipment | 16.2% |
| Tasa de crecimiento de los ingresos | 62.1% |
| Rentabilidad financiera futura | n/a |
| Cobertura de analistas | Low |
| Última actualización | 11 Sep 2023 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 12/31/2025 | 118 | N/A | N/A | N/A | 1 |
| 12/31/2024 | 42 | N/A | N/A | N/A | 1 |
| 12/31/2023 | 26 | N/A | N/A | N/A | 1 |
| 3/31/2023 | 25 | -6 | -4 | -4 | N/A |
| 12/31/2022 | 25 | -3 | -1 | -1 | N/A |
| 9/30/2022 | 23 | -3 | -1 | -1 | N/A |
| 6/30/2022 | 20 | -4 | -2 | -2 | N/A |
| 3/31/2022 | 18 | -5 | -3 | -3 | N/A |
| 12/31/2021 | 15 | -5 | -3 | -3 | N/A |
| 9/30/2021 | 16 | -4 | 0 | 0 | N/A |
| 6/30/2021 | 17 | -3 | 2 | 2 | N/A |
| 3/31/2021 | 17 | -1 | 3 | 3 | N/A |
| 12/31/2020 | 17 | 1 | 4 | 4 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: Insufficient data to determine if 0HB's forecast earnings growth is above the savings rate (0.4%).
Beneficios vs. Mercado: Insufficient data to determine if 0HB's earnings are forecast to grow faster than the German market
Beneficios de alto crecimiento: Insufficient data to determine if 0HB's earnings are expected to grow significantly over the next 3 years.
Ingresos vs. Mercado: 0HB's revenue (62.1% per year) is forecast to grow faster than the German market (3.7% per year).
Ingresos de alto crecimiento: 0HB's revenue (62.1% per year) is forecast to grow faster than 20% per year.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Insufficient data to determine if 0HB's Return on Equity is forecast to be high in 3 years time